- Business
- RTX A/S is a Denmark-based technology company that designs, develops, manufactures and sells wireless communication solutions for enterprise, professional audio and healthcare applications. RTX A/S operates through three primary segments offering wireless IP telephony products and subsystems including headsets, handsets, base stations, repeaters, location beacons and cloud-based deployment and device management tools; professional audio solutions encompassing microphone and instrument connectivity, wireless gaming headsets and peripherals, conference systems, content creation solutions and intercom systems for restaurants, construction sites, TV productions and large sporting events including the TeamEngage and Sheerlink platforms; and healthcare products such as wireless modules for continuous patient monitoring in hospitals. The company provides customized turnkey end-to-end solutions with full product lifecycle management to global B2B customers including brands such as Microsoft, Philips Healthcare, Siemens, Panasonic, NEC and Sennheiser, and its solutions incorporate technologies like Wi-Fi, DECT radio and VoIP for small and medium enterprises. Founded in 1993 and headquartered in Noerresundby, Denmark, RTX A/S conducts operations in Denmark, France, Germany, rest of Europe, the United States, Hong Kong, other Asia-Pacific regions and internationally through subsidiaries including RTX America Inc, RTX Hong Kong Ltd and RTX Telecom Telecomunicacoes Ltda. In recent developments, RTX A/S initiated a DKK 20 million share buy-back program in August 2025 pursuant to authorization from its January 2024 Annual General Meeting; released its 2024/25 annual report in November 2025 highlighting significant financial progress, double-digit revenue growth expectations net of currency effects for 2025/26, and long-term ambitions toward 2030 including double-digit annual revenue growth and EBITDA margin above 15% driven by a market-driven platform-based scalable technology strategy; and continues ongoing share buy-back executions as announced in October 2025.